Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2003 1
2006 2
2016 1
2019 18
2020 6158
2021 10955
2022 9200
2023 6975
2024 1554

Text availability

Article attribute

Article type

Publication date

Search Results

30,655 results

Results by year

Filters applied: . Clear all
The following terms were ignored: #, )
Quoted phrases not found in phrase index: "COVID-19", "severe acute respiratory syndrome coronavirus 2"
Page 1
Efficacy and safety of COVID-19 vaccines.
Graña C, Ghosn L, Evrenoglou T, Jarde A, Minozzi S, Bergman H, Buckley BS, Probyn K, Villanueva G, Henschke N, Bonnet H, Assi R, Menon S, Marti M, Devane D, Mallon P, Lelievre JD, Askie LM, Kredo T, Ferrand G, Davidson M, Riveros C, Tovey D, Meerpohl JJ, Grasselli G, Rada G, Hróbjartsson A, Ravaud P, Chaimani A, Boutron I. Graña C, et al. Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD015477. doi: 10.1002/14651858.CD015477. Cochrane Database Syst Rev. 2022. PMID: 36473651 Free PMC article. Review.
BACKGROUND: Different forms of vaccines have been developed to prevent the SARS-CoV-2 virus and subsequent COVID-19 disease. Several are in widespread use globally. OBJECTIVES: To assess the efficacy and safety of COVID-19 vacci
BACKGROUND: Different forms of vaccines have been developed to prevent the SARS-CoV-2 virus and subsequent COVID
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.
Zhang JJ, Dong X, Liu GH, Gao YD. Zhang JJ, et al. Clin Rev Allergy Immunol. 2023 Feb;64(1):90-107. doi: 10.1007/s12016-022-08921-5. Epub 2022 Jan 19. Clin Rev Allergy Immunol. 2023. PMID: 35044620 Free PMC article. Review.
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global health crisis. ... …
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe acute respi
COVID-19 in Children: Where do we Stand?
Nikolopoulou GB, Maltezou HC. Nikolopoulou GB, et al. Arch Med Res. 2022 Jan;53(1):1-8. doi: 10.1016/j.arcmed.2021.07.002. Epub 2021 Jul 6. Arch Med Res. 2022. PMID: 34311990 Free PMC article. Review.
From the beginning of the coronavirus disease 2019 (COVID-19) pandemic it became evident that children infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
From the beginning of the coronavirus disease 2019 (COVID-19) pandemic it became evident that children in …
Myocarditis With COVID-19 mRNA Vaccines.
Bozkurt B, Kamat I, Hotez PJ. Bozkurt B, et al. Circulation. 2021 Aug 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul 20. Circulation. 2021. PMID: 34281357 Free PMC article. Review.
Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) mRNA vaccinations, especially in young adult and adolescent males. ...Although the mechanisms for development of myocarditis are not clear, molecular mimicry …
Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) mRNA vaccinations, especi …
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.
Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, Watkinson P, Khunti K, Harnden A, Coupland CAC, Channon KM, Mills NL, Sheikh A, Hippisley-Cox J. Patone M, et al. Circulation. 2022 Sep 6;146(10):743-754. doi: 10.1161/CIRCULATIONAHA.122.059970. Epub 2022 Aug 22. Circulation. 2022. PMID: 35993236 Free PMC article.
BACKGROUND: Myocarditis is more common after severe acute respiratory syndrome coronavirus 2 infection than after COVID-19 vaccination, but the risks in younger people and after sequential vaccine doses are less certain. ... …
BACKGROUND: Myocarditis is more common after severe acute respiratory syndrome coronavirus 2 infec …
Mental health status of COVID-19 survivors: a cross sectional study.
Jafri MR, Zaheer A, Fatima S, Saleem T, Sohail A. Jafri MR, et al. Virol J. 2022 Jan 6;19(1):3. doi: 10.1186/s12985-021-01729-3. Virol J. 2022. PMID: 34991632 Free PMC article.
BACKGROUND: Coronavirus disease-19 (COVID-19) is a communicable disease caused by a virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pandemics are associated with th …
BACKGROUND: Coronavirus disease-19 (COVID-19) is a communicable disease caused by a virus named severe acute
Vaccinating children against SARS-CoV-2.
Lavine JS, Bjornstad O, Antia R. Lavine JS, et al. BMJ. 2021 May 13;373:n1197. doi: 10.1136/bmj.n1197. BMJ. 2021. PMID: 33985969 No abstract available.
Diagnostic testing for SARS-CoV-2/COVID19.
Spearman P. Spearman P. Curr Opin Pediatr. 2021 Feb 1;33(1):122-128. doi: 10.1097/MOP.0000000000000972. Curr Opin Pediatr. 2021. PMID: 33278110 Review.
PURPOSE OF REVIEW: SARS-CoV-2 is the novel human coronavirus responsible for the COVID19 pandemic. ...The purpose of this review is to describe current diagnostic modalities for SARS-CoV-2 and outline their use. Speci …
PURPOSE OF REVIEW: SARS-CoV-2 is the novel human coronavirus responsible for the COVID19 pandemic. …
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
Link-Gelles R, Ciesla AA, Fleming-Dutra KE, Smith ZR, Britton A, Wiegand RE, Miller JD, Accorsi EK, Schrag SJ, Verani JR, Shang N, Derado G, Pilishvili T. Link-Gelles R, et al. MMWR Morb Mortal Wkly Rep. 2022 Dec 2;71(48):1526-1530. doi: 10.15585/mmwr.mm7148e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36454688 Free PMC article.
On September 1, 2022, bivalent COVID-19 mRNA vaccines, composed of components from the SARS-CoV-2 ancestral and Omicron BA.4/BA.5 strains, were recommended by the Advisory Committee on Immunization Practices (ACIP) to address reduced effectivene …
On September 1, 2022, bivalent COVID-19 mRNA vaccines, composed of components from the SARS-CoV-2 ancestr …
COVID-19 infections in infants.
Sobolewska-Pilarczyk M, Pokorska-Śpiewak M, Stachowiak A, Marczyńska M, Talarek E, Ołdakowska A, Kucharek I, Sybilski A, Mania A, Figlerowicz M, Mazur-Melewska K, Potocka P, Sulik A, Hasiec B, Stani M, Frańczak-Chmura P, Szczepańska B, Pałyga-Bysiecka I, Ciechanowski P, Łasecka-Zadrożna J, Zaleska I, Szenborn L, Dryja U, Kuchar E, Niedźwiecka S, Kalicki B, Flisiak R, Pawłowska M. Sobolewska-Pilarczyk M, et al. Sci Rep. 2022 May 11;12(1):7765. doi: 10.1038/s41598-022-11068-0. Sci Rep. 2022. PMID: 35546159 Free PMC article.
Gastrointestinal symptoms are common in infants infected with SARS-CoV-2, and infant appetite disorders may lead to hospitalization. The clinical course of the disease differed significantly between the first and second wave of the pandemic
Gastrointestinal symptoms are common in infants infected with SARS-CoV-2, and infant appetite disorders m …
30,655 results
You have reached the last available page of results. Please see the User Guide for more information.